Conexiant Dental recently highlighted Forward Science's ongoing commitment to fighting oral cancer with OralID. As the U.S. braces for over 2 million new cancer cases in 2024, oral cancer remains a critical concern due to stagnant survival rates over the past three decades. Despite its preventability and treatability when detected early, oral cancer often goes undiagnosed until it's too late. Forward Science celebrates its eleventh Oral Cancer Awareness Month by championing oral cancer screening with OralID. This innovative tool empowers clinicians to visualize abnormalities not visible in traditional exams, especially important as oral cancer rates rise among young non-smokers. Forward Science CEO Robert J. Whitman emphasizes that oral cancer awareness is a year-round mission, and their partnership with healthcare professionals aims to transform lives through advanced technology and education.
Click HERE to read the full article about Forward Science’s efforts and the impact of OralID.